News

Why bats can harbor viruses like hantavirus and coronavirus—pathogens that are highly dangerous to humans—without becoming ...
New research zeroes in on a unique group of immune cells that could transform how we treat—and possibly prevent—severe food allergies like peanut and shellfish.
This important work presents a stochastic branching process model of tumour-immune coevolution, incorporating stochastic antigenic mutation accumulation and escape within the cancer cell population.
Scientists have discovered a new immunotherapy strategy that reduces cancer recurrence in mouse experimental models. The study, published in Nature Communications, shows that a specific subtype of ...
The Lupus Research Alliance (LRA) is proud to announce the recipients of this year’s Lupus Innovation Award (LIA), addressing many critical themes in lupus research including novel therapeutic ...
Researchers have found that tapping into the body's own immune system and activating a type of immune cell known as B cells, could be the key to boosting the effectiveness of tumor-infiltrating ...
Technological advances empower the modification of NK cells and renewed potential for therapeutic uses in cancer and ...
GloboCare announced that it has been granted the patent right and Certificate of Invention for its CAR-T and CAR-NK cell ...
Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a commercial-stage company dedicated to developing and delivering precision diagnostic consumer products, announced today that it has ...
The following is a summary of “A gold nanoparticle/peptide vaccine designed to induce SARS-CoV-2-specific CD8 T cells: a double-blind, randomized, phase 1 study in Switzerland,” published in the April ...
An Indian biotech start-up led by a Kashmir scientist has a patented, 3rd-generation CAR-T therapy that targets cancer ...
Even in the case of uncomplicated infections, the body prepares itself early on for the possibility of a more severe course.